Theravance Biopharma, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2013 | $-28.5M | $-29.2M | $740.0K | $5.5M |
| Jun 2013 | $-24.3M | $-25.0M | $691.0K | $6.2M |
| Sep 2013 | $-32.9M | $-33.2M | $237.0K | $5.6M |
| Dec 2013 | $-35.2M | $-36.3M | $1.1M | $5.2M |
| Mar 2014 | $-44.8M | $-46.4M | $1.6M | $12.7M |
| Jun 2014 | $-51.4M | $-51.7M | $261.0K | $6.8M |
| Sep 2014 | $-36.4M | $-36.8M | $461.0K | $9.4M |
| Dec 2014 | $-42.5M | $-43.3M | $765.0K | $14.4M |
| Mar 2015 | $-56.5M | $-57.2M | $657.0K | $15.6M |
| Jun 2015 | $-46.6M | $-47.3M | $710.0K | $14.7M |
| Sep 2015 | $-32.0M | $-32.7M | $674.0K | $12.3M |
| Dec 2015 | $-33.7M | $-34.4M | $606.0K | $11.5M |
| Mar 2016 | $-26.3M | $-27.0M | $684.0K | $11.3M |
| Jun 2016 | $-32.1M | $-32.8M | $638.0K | $9.9M |
| Sep 2016 | $-12.4M | $-12.8M | $413.0K | $9.9M |
| Dec 2016 | $-28.1M | $-28.5M | $400.0K | $10.0M |
| Mar 2017 | $-50.0M | $-50.6M | $587.0K | $10.3M |
| Jun 2017 | $-44.5M | $-45.3M | $738.0K | $10.4M |
| Sep 2017 | $-62.3M | $-63.1M | $826.0K | $10.7M |
| Dec 2017 | $-44.2M | $-44.5M | $255.0K | $17.8M |
| Mar 2018 | $49.8M | $47.1M | $2.8M | $14.0M |
| Jun 2018 | $-61.5M | $-62.6M | $1.1M | $13.9M |
| Sep 2018 | $-49.0M | $-50.9M | $1.9M | $11.7M |
| Dec 2018 | $-52.2M | $-53.7M | $1.5M | $11.7M |
| Mar 2019 | $-81.2M | $-82.4M | $1.2M | $12.2M |
| Jun 2019 | $-48.0M | $-48.6M | $576.0K | $11.3M |
| Sep 2019 | $-44.6M | $-44.7M | $77.0K | $13.0M |
| Dec 2019 | $-64.4M | $-65.7M | $1.3M | $23.9M |
| Mar 2020 | $-55.1M | $-56.1M | $954.0K | $15.3M |
| Jun 2020 | $-53.3M | $-55.7M | $2.4M | $16.6M |
| Sep 2020 | $-77.0M | $-79.1M | $2.1M | $15.6M |
| Dec 2020 | $-64.9M | $-66.2M | $1.2M | $15.6M |
| Mar 2021 | $-69.9M | $-71.6M | $1.8M | $15.8M |
| Jun 2021 | $-50.1M | $-50.3M | $156.0K | $14.9M |
| Sep 2021 | $-45.4M | $-46.5M | $1.0M | $14.4M |
| Dec 2021 | $-42.4M | $-42.9M | $444.0K | $16.9M |
| Mar 2022 | $-26.1M | $-26.3M | $250.0K | $14.5M |
| Jun 2022 | $-14.7M | $-14.8M | $113.0K | $9.7M |
| Sep 2022 | $-22.1M | $-22.1M | $-57.0K | $8.5M |
| Dec 2022 | $-124.1M | $-124.3M | $266.0K | $7.0M |
| Mar 2023 | $-11.2M | $-12.2M | $938.0K | $7.0M |
| Jun 2023 | $-12.4M | $-13.3M | $852.0K | $6.3M |
| Sep 2023 | $-2.5M | $-2.5M | $21.0K | $6.3M |
| Dec 2023 | $-854.0K | $-1.5M | $677.0K | $5.8M |
| Mar 2024 | $-1.0M | $-1.1M | $91.0K | $5.2M |
| Jun 2024 | $-4.4M | $-4.5M | $36.0K | $5.4M |
| Sep 2024 | $-5.2M | $-5.2M | $15.0K | $5.0M |
| Dec 2024 | $-902.0K | $-1.1M | $190.0K | $5.8M |
| Mar 2025 | $43.0M | $43.0M | — | $4.9M |
| Jun 2025 | $208.1M | $208.1M | — | $4.5M |
| Sep 2025 | $-6.5M | $-6.5M | — | $4.6M |
| Dec 2025 | $-6.1M | $-6.1M | — | $4.5M |
| Mar 2026 | $73.3M | $73.3M | — | $4.5M |
| Jun 2026 | $-7.0M | $-7.0M | — | $6.0M |